Work

Phase II trial of Ontak to deplete regulatory T cells in treatment-refractory stage III/IV ovarian cancer

Year: 2006

Type: article

Study design: Clinical Trial

Source: Cancer Research

Authors: Brian Barnett, Jens Rüter, Pui Cheng, Inka Kryczek, Michael J. Brumlik, Jonathan F. Head, Robert L. Elliott, Weiping Zou, Tyler J. Curiel

Institution: Tulane University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1573428883

FWCI:

Cites:

Cited by: 1

Related to: 20